Replies to post #3 on Clearside BioMedical Inc (CLSD)

[finesand]

thx, that was the failure Nov'18: Phase-3 XIPERE used together with the EYLEA® .. for the treatment of retinal vein occlusion (‘RVO”) http://ir.clearsidebio.com/news-releases/news-release-details/clearside-biomedical-announces-sapphire-phase-3-study